Literature DB >> 21878565

Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling.

Keira Joann Herr1, Deron R Herr, Chang-Wook Lee, Kyoko Noguchi, Jerold Chun.   

Abstract

Fetal hypoxia is a common risk factor that has been associated with a range of CNS disorders including epilepsy, schizophrenia, and autism. Cellular and molecular mechanisms through which hypoxia may damage the developing brain are incompletely understood but are likely to involve disruption of the laminar organization of the cerebral cortex. Lysophosphatidic acid (LPA) is a bioactive lipid capable of cortical influences via one or more of six cognate G protein-coupled receptors, LPA(1-6), several of which are enriched in fetal neural progenitor cells (NPCs). Here we report that fetal hypoxia induces cortical disruption via increased LPA(1) signaling involving stereotyped effects on NPCs: N-cadherin disruption, displacement of mitotic NPCs, and impaired neuronal migration, as assessed both ex vivo and in vivo. Importantly, genetic removal or pharmacological inhibition of LPA(1) prevented the occurrence of these hypoxia-induced phenomena. Hypoxia resulted in overactivation of LPA(1) through selective inhibition of G protein-coupled receptor kinase 2 expression and activation of downstream pathways including G(αi) and Ras-related C3 botulinum toxin substrate 1. These data identify stereotyped and selective hypoxia-induced cerebral cortical disruption requiring LPA(1) signaling, inhibition of which can reduce or prevent disease-associated sequelae, and may take us closer to therapeutic treatment of fetal hypoxia-induced CNS disorders and possibly other forms of hypoxic injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878565      PMCID: PMC3174597          DOI: 10.1073/pnas.1106129108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis.

Authors:  Adrienne E Dubin; Deron R Herr; Jerold Chun
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; R A Bundey; P C Prodanovich; P Fagan; C S Baccei; A M Santini; J H Hutchinson; T J Seiders; T A Parr; P Prasit; J F Evans; D S Lorrain
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.

Authors:  Ji Woong Choi; Shannon E Gardell; Deron R Herr; Richard Rivera; Chang-Wook Lee; Kyoko Noguchi; Siew Teng Teo; Yun C Yung; Melissa Lu; Grace Kennedy; Jerold Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-21       Impact factor: 11.205

Review 4.  LPA receptors: subtypes and biological actions.

Authors:  Ji Woong Choi; Deron R Herr; Kyoko Noguchi; Yun C Yung; Chang-Wook Lee; Tetsuji Mutoh; Mu-En Lin; Siew T Teo; Kristine E Park; Alycia N Mosley; Jerold Chun
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

5.  Impaired migration signaling in the hippocampus following prenatal hypoxia.

Authors:  M Hava Golan; Revital Mane; Gabriela Molczadzki; Michal Zuckerman; Vered Kaplan-Louson; Mahmoud Huleihel; J Regino Perez-Polo
Journal:  Neuropharmacology       Date:  2009-07-25       Impact factor: 5.250

Review 6.  The neurodevelopmental hypothesis of schizophrenia, revisited.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

7.  Mammalian Par3 regulates progenitor cell asymmetric division via notch signaling in the developing neocortex.

Authors:  Ronald S Bultje; David R Castaneda-Castellanos; Lily Yeh Jan; Yuh-Nung Jan; Arnold R Kriegstein; Song-Hai Shi
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

8.  Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.

Authors:  Huafeng Zhang; David Z Qian; Yee Sun Tan; Kangae Lee; Ping Gao; Yunzhao R Ren; Sergio Rey; Hans Hammers; Daniel Chang; Roberto Pili; Chi V Dang; Jun O Liu; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

Review 9.  Hypoxia-inducible factors and the response to hypoxic stress.

Authors:  Amar J Majmundar; Waihay J Wong; M Celeste Simon
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

10.  A new subtype of progenitor cell in the mouse embryonic neocortex.

Authors:  Xiaoqun Wang; Jin-Wu Tsai; Bridget LaMonica; Arnold R Kriegstein
Journal:  Nat Neurosci       Date:  2011-04-10       Impact factor: 24.884

View more
  30 in total

Review 1.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

Review 2.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development.

Authors:  Deron R Herr; Chang-Wook Lee; Wei Wang; Adam Ware; Richard Rivera; Jerold Chun
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

4.  Stereotypical alterations in cortical patterning are associated with maternal illness-induced placental dysfunction.

Authors:  Pamela A Carpentier; Ursula Haditsch; Amy E Braun; Andrea V Cantu; Hyang Mi Moon; Robin O Price; Matthew P Anderson; Vidya Saravanapandian; Khadija Ismail; Moises Rivera; James M Weimann; Theo D Palmer
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

5.  Molecular regulation of lysophosphatidic acid receptor 1 trafficking to the cell surface.

Authors:  Jing Zhao; Jianxin Wei; Rachel K Bowser; Su Dong; Shuqi Xiao; Yutong Zhao
Journal:  Cell Signal       Date:  2014-07-13       Impact factor: 4.315

6.  Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults.

Authors:  Karolina A Aberg; Joseph L McClay; Srilaxmi Nerella; Shaunna Clark; Gaurav Kumar; Wenan Chen; Amit N Khachane; Linying Xie; Alexandra Hudson; Guimin Gao; Aki Harada; Christina M Hultman; Patrick F Sullivan; Patrik K E Magnusson; Edwin J C G van den Oord
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

7.  Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.

Authors:  Brigitte Anliker; Ji Woong Choi; Mu-En Lin; Shannon E Gardell; Richard R Rivera; Grace Kennedy; Jerold Chun
Journal:  Glia       Date:  2013-09-24       Impact factor: 7.452

Review 8.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

9.  Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.

Authors:  Estibaliz González de San Román; Iván Manuel; María Teresa Giralt; Jerold Chun; Guillermo Estivill-Torrús; Fernando Rodríguez de Fonseca; Luis Javier Santín; Isidro Ferrer; Rafael Rodríguez-Puertas
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

Review 10.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.